OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $138,000 | +21.1% | 10,227 | 0.0% | 0.00% | – |
Q3 2018 | $114,000 | -72.8% | 10,227 | -88.0% | 0.00% | – |
Q4 2016 | $419,000 | +8.8% | 85,328 | +10.0% | 0.00% | – |
Q3 2016 | $385,000 | -10.0% | 77,598 | -7.7% | 0.00% | – |
Q2 2016 | $428,000 | -26.5% | 84,058 | -17.7% | 0.00% | – |
Q1 2016 | $582,000 | -36.0% | 102,082 | +16.4% | 0.00% | – |
Q4 2015 | $910,000 | -40.3% | 87,697 | +6.3% | 0.00% | – |
Q3 2015 | $1,524,000 | -22.3% | 82,487 | -18.2% | 0.00% | -100.0% |
Q2 2015 | $1,961,000 | +17.4% | 100,798 | +6.1% | 0.00% | – |
Q1 2015 | $1,670,000 | +7.5% | 95,004 | -2.2% | 0.00% | – |
Q4 2014 | $1,553,000 | +33.2% | 97,142 | +4.9% | 0.00% | – |
Q3 2014 | $1,166,000 | -54.6% | 92,646 | -43.6% | 0.00% | – |
Q2 2014 | $2,566,000 | +138.3% | 164,344 | +100.3% | 0.00% | – |
Q1 2014 | $1,077,000 | -18.0% | 82,057 | +0.4% | 0.00% | – |
Q4 2013 | $1,314,000 | -53.3% | 81,709 | -51.6% | 0.00% | – |
Q3 2013 | $2,812,000 | +186.1% | 168,994 | +73.0% | 0.00% | – |
Q2 2013 | $983,000 | – | 97,699 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cloverdale Capital Management, LLC | 324,722 | $6,170,000 | 3.39% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,233,589 | $23,437,000 | 0.77% |
Beryl Capital Management LLC | 220,189 | $4,184,000 | 0.77% |
BERKLEY W R CORP | 109,601 | $2,082,000 | 0.44% |
WATER ISLAND CAPITAL LLC | 514,970 | $9,784,000 | 0.27% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 91,411 | $1,737,000 | 0.22% |
DELTEC ASSET MANAGEMENT LLC | 50,000 | $950,000 | 0.21% |
Versor Investments LP | 113,905 | $2,164,000 | 0.21% |
ALGERT GLOBAL LLC | 14,774 | $281,000 | 0.16% |
Hillsdale Investment Management Inc. | 92,941 | $1,766,000 | 0.16% |